As shown in Fig. 1 and Fig. 2, LPA1, LPA4 and LPA5 immunoreactivity were significantly higher in the adenomyosis group than in the control group, while LPA2 and LPA3 immunoreactivity were significantly lower in the adenomyosis group than in the control group. The gene discussed is LPAR5; the disease is adenomyosis.